Control of patient information in the COVID-19 era
An expert panel discussed the COPI notice extensions and implications for biomedical research and regulation
How should confidential patient information be used in the future? Our report on the COPI notices explores this question and more. View it here.
Following the release of the PHG Foundation's in-depth report on the Control of Patient Information (COPI) notice extensions during the COVID-19 pandemic, on 6 December we discussed the key findings.
The new report, released on 30 November, considers how regulatory changes to the governance of patient information have impacted genomic and medical research, and whether these changes should be integrated into the regulatory framework longer-term.
An interactive panel of experts reacted to the findings, and add their own valuable insights.
Watch the recorded discussion here:
Chaired by Dr Colin Mitchell, Acting Head of Humanities, PHG Foundation, the panel included:
Director, Centre for Personalised Medicine
University of Oxford
Health Data Research UK (HDR UK)
Head of Policy, Public Affairs and Research and Insight
Senior Advisor (Humanities), PHG Foundation